Frontlight ResearchEarly access
Active, not recruitingPhase 4
Painful Inflammatory Carpometacarpal-1 osteoArthritis treated with intraarticular Steroids, Saline or an Occupational therapy intervention: the PICASSO trial
Key facts
- Who runs it
- Diakonhjemmet Sykehus AS
- Where
- Norway6 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 4
- People taking part
- 354 people, planned
- Started
- 3 Nov 2023
- Expected to end
- 1 Oct 2028
- Type of study
- Interventional
- Record updated
- 26 June 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- Men and women between 40-85 years of age
- Osteoarthritis in target CMC-1 joint confirmed by radiographs or ultrasound examination
- Inflammation in target CMC-1 joint confirmed by ultrasound (grey scale synovitis grade 1-3)
- Pain in target CMC-1 joint of at least 3 on a 0-10 Numeric rating scale (NRS) at rest or during activities at both pre-screening and screening
- Patient is assessed as eligible for the proposed use of Kenacort-T
Who cannot take part
- Patients vaccinated or immunized with live virus vaccines in the last 2 weeks
- More than three previous IACS injections in the target CMC-1 joint
- Use of oral, intramuscular, or intravenous steroids in the last 12 weeks
- Previous surgery of the target CMC-1 joint
- Planned hand surgery in the coming 24 weeks
- Systemic inflammatory joint diseases (including but not limited to rheumatoid arthritis (RA), psoriatic arthritis or gout) or other conditions that can better explain the hand pain (such as thoracic outlet syndrome, carpal tunnel disease, diabetic cheiropathy, hand injury in previous six months, or palmar tenosynovitis/trigger finger)
- Infection, skin disease or wounds at joint injection site
- Serious comorbidities, cognitive dysfunction, substance/alcohol abuse or any other medical condition that makes adherence to the study protocol difficult
- Severe or uncontrolled infections
- Any condition that in the view of the investigator would suggest that the patient is unable to comply with the study protocol and procedures
- Known hypersensitivity to Triamcinolone acetonide (Kenacort) or any of the excipients (sodium carboxymethylcellulose, sodium chloride, polysorbate, benzyl alcohol, sodium hydroxide or hydrochloric acid)
- Use of thumb orthosis on most of the days or structured hand exercises in the last 12 weeks
- Diagnosis of psoriasis
- Use of digitalis glycosides
- Included in another clinical study
- Not being able to speak or understand Norwegian
- Intraarticular injections in the target CMC-1 joint in the last 12 weeks
- Known pregnancy or planned pregnancy in the next 6 months
- Refuse to quit using oral or topical NSAIDs on the hands (such as ibuprofen, diclofenac, etoricoxib, naproxen) in the next 12 weeks
- Diagnosis of fibromyalgia
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To assess whether intraarticular corticosteroid (IACS) injections are superior to saline injections after 4 weeks, and compare the efficacy of IACS injections, saline injections and a multimodal occupational therapy intervention after 12 weeks in patients with painful inflammatory OA in the first carpometacarpal joint.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 26 June 2025